Product NDC: | 65197-300 |
Proprietary Name: | Gelusil |
Non Proprietary Name: | aluminum hydroxide dried gel and magnesium hydroxide and simethicone |
Active Ingredient(s): | 200; 24; 200; 1 mg/1; mg/1; mg/1; mg/1 & nbsp; aluminum hydroxide dried gel and magnesium hydroxide and simethicone |
Administration Route(s): | ORAL |
Dosage Form(s): | TABLET, CHEWABLE |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 65197-300 |
Labeler Name: | WellSpring Pharmaceutical Corporation |
Product Type: | HUMAN OTC DRUG |
FDA Application Number: | part331 |
Marketing Category: | OTC MONOGRAPH FINAL |
Start Marketing Date: | 20080924 |
Package NDC: | 65197-300-20 |
Package Description: | 2 BLISTER PACK in 1 CARTON (65197-300-20) > 10 TABLET, CHEWABLE in 1 BLISTER PACK |
NDC Code | 65197-300-20 |
Proprietary Name | Gelusil |
Package Description | 2 BLISTER PACK in 1 CARTON (65197-300-20) > 10 TABLET, CHEWABLE in 1 BLISTER PACK |
Product NDC | 65197-300 |
Product Type Name | HUMAN OTC DRUG |
Non Proprietary Name | aluminum hydroxide dried gel and magnesium hydroxide and simethicone |
Dosage Form Name | TABLET, CHEWABLE |
Route Name | ORAL |
Start Marketing Date | 20080924 |
Marketing Category Name | OTC MONOGRAPH FINAL |
Labeler Name | WellSpring Pharmaceutical Corporation |
Substance Name | ALUMINUM HYDROXIDE; DIMETHICONE 410; MAGNESIUM HYDROXIDE; SILICON DIOXIDE |
Strength Number | 200; 24; 200; 1 |
Strength Unit | mg/1; mg/1; mg/1; mg/1 |
Pharmaceutical Classes |